ScholarIQanswers from OpenAlex & ORCID
Isabelle Ayoub
ResearcherPublications, citations & collaboration network
Isabelle Ayoub is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Isabelle Ayoub have?
ScholarIQindexed works
Isabelle Ayoub has 115 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Isabelle Ayoub have?
ScholarIQcitation count
Isabelle Ayoub has 2,718 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Isabelle Ayoub?
ScholarIQh-index
Isabelle Ayoub has an h-index of 25 in OpenAlex.
What is the i10-index of Isabelle Ayoub?
ScholarIQi10-index
Isabelle Ayoub has an i10-index of 39 in OpenAlex.
What is the ORCID of Isabelle Ayoub?
ScholarIQorcid
The ORCID for Isabelle Ayoub is on the source record.
What is the OpenAlex record for Isabelle Ayoub?
ScholarIQopenalex
The OpenAlex for Isabelle Ayoub is on the source record.
What are the most-cited papers on Isabelle Ayoub?
ScholarIQmost cited works
KDIGO 2024 Clinical Practice Guideline for the management of LUPUS NEPHRITIS
Brad H. Rovin, Isabelle Ayoub, Tak Mao Chan, Zhi-Hong Liu, Juan M. Mejía‐Vilet, Jürgen Floege
Management and treatment of glomerular diseases (part 1): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
Jürgen Floege, Sean Barbour, Daniel Cattran, Jonathan J. Hogan, Patrick H. Nachman, Sydney Tang, Jack F.M. Wetzels, Michael Cheung, David C. Wheeler, Wolfgang C. Winkelmayer, Brad H. Rovin, Sharon G. Adler, Charles E. Alpers, Isabelle Ayoub, Arvind Bagga, Jonathan Barratt, Dawn J. Caster, Daniel T.M. Chan, Anthony Chang, Jason Choo, H. Terence Cook, Rosanna Coppo, Fernando C. Fervenza, Agnes B. Fogo, J. G. Fox, Keisha L. Gibson, Richard J. Glassock, David C.H. Harris, Elisabeth M Hodson, Elion Hoxha, Kunitoshi Iseki, J. Charles Jennette, Vivekanand Jha, David W. Johnson, Shinya Kaname, Ritsuko Katafuchi, A. Richard Kitching, Richard Lafayette, Philip Kam‐Tao Li, Adrian Liew, Jicheng Lv, Ana Malvar, Shoichi Maruyama, Juan M. Mejía‐Vilet, Marcus J. Moeller, Chi Chiu Mok, Carla Nester, Eisei Noiri, Michelle M. O’Shaughnessy, Seza Özen, Samir M. Parikh, Hyeong Cheon Park, Chen Au Peh, William F. Pendergraft, Matthew C. Pickering, Évangéline Pillebout, Jai Radhakrishnan, Manish Rathi, Dario Roccatello, Pierre Ronco, William E. Smoyer, Vladimı́r Tesař, Joshua M. Thurman, Hernán Trimarchi, Marina Vivarelli, Giles Walters, Angela Yee‐Moon Wang, Scott E. Wenderfer
Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial
Hiddo J.L. Heerspink, Jai Radhakrishnan, Charles E. Alpers, Jonathan Barratt, Stewart Bieler, Ulysses Diva, Jula K. Inrig, Radko Komers, Alex Mercer, Irene L. Noronha, Michelle N. Rheault, William E. Rote, Brad H. Rovin, Howard Trachtman, Hernán Trimarchi, Muh Geot Wong, Vlado Perkovic, Eric Alarmartine, Jonathan Barratt, Dong‐Wan Chae, Lucia Del Vecchio, Jürgen Floege, Shang‐Jyh Hwang, Bojan Jelaković, Bart Maes, Robert Małecki, Marius Miglinas, Fernando Nolasco, M Praga, Kannaiyan S Rabindranath, Mai Rosenberg, Brad H. Rovin, Sydney Tang, Vladmir Tesar, Muh Geot Wong, Bhadran Bose, Muralikrishna Gangadharan, Stephen P. McDonald, Chen Au Peh, Sadia Jahan, Chii Yeap, Philip A. Clayton, Georgina Irish, Nikhil Thyagarajan, Peter Hollett, Rathika Krishnasamy, Robert J. Carroll, Shilpanjali Jesudason, Susan Crail, Toby Coates, Jane Waugh, Euan Noble, Kumaradevan Mahadevan, Victoria Campbell, Tania Salehi, Wai H. Lim, Neil Boudville, Aron Chakera, Doris Chan, Anoushka Krishnan, Yusuf Eqbal, Alastair Gillies, Eswari Vilayur, Thida Maung Myint, Nicholas A. Gray, Jane Waugh, Euan Noble, Melissa S Cheetham, Yusuf Eqbal, Peter Hollett, Rathika Krishnasamy, Kumaradevan Mahadevan, Victoria Campbell, Carol A. Pollock, Bruce A. Cooper, Amanda Mather, Sarah Roxburgh, Yvonne Shen, Stefanie Stangenberg, Amanda Siriwardana, Emma O’Lone, Susan Wan, Brendon L. Neuen, Jeffrey T. Ha, Dana Kim, Lauren Heath, Arunima Jain, Elaine Phua, Li Yan, M. W. Gallagher, Meg Jardine, Angus Ritchie, Mona Razavian, Celine Foote, Roger Wyndham, Shaundeep Sen, Zoltán Endre, Jonathan Erlich, Mangalee Fernando, Kenneth Yong
Results from part A of the multi-center, double-blind, randomized, placebo-controlled NefIgArd trial, which evaluated targeted-release formulation of budesonide for the treatment of primary immunoglobulin A nephropathy
Jonathan Barratt, Richard Lafayette, Jens Kristensen, Andrew Stone, Daniel Cattran, Jürgen Floege, Vladimı́r Tesař, Hernán Trimarchi, Hong Zhang, Necmi Eren, Alexander Paliege, Brad H. Rovin, Guillermo Fragale, Alejandra Karl, Patricia Losisolo, Hernán Trimarchi, Ivan Gonzalez Hoyos, Mauro Lampo, Matías Monkowski, Jorge de la Fuente, Magdalena Alvarez, Daniela Stoppa, Carlos Chiurchiu, P. Novoa, Marcelo Orías, Maria Belen Barron, Ana Paula Giotto, M. Arriola, Evelin Cassini, Rafaël Maldonado, Maria Paula Dionisi, Jessica Ryan, Nigel D. Toussaint, Grant Luxton, Chen Au Peh, Vicki Levidiotis, Ross S. Francis, Richard Phoon, Elena Fedosiuk, D.M. Toropilov Toropilov, R. E. Yakubtsevich, Elena Mikhailova, Christophe Bovy, Nathalie Demoulin, Jean‐Michel Hougardy, Bart Maes, Marijn M. Speeckaert, Louis‐Philippe Laurin, Sean Barbour, Mélanie Masse, Michelle Hladunewich, Heather N. Reich, Serge Cournoyer, Karthik Tennankore, Sean Barbour, Jicheng Lv, Zhangsuo Liu, Caili Wang, Shaomei Li, Qun Luo, Zhaohui Ni, Tiekun Yan, Ping Fu, Hong Cheng, Bi‐Cheng Liu, Wanhong Lu, Jianqin Wang, Qinkai Chen, D. Wang, Zuying Xiong, Menghua Chen, Yan Xu, Jiali Wei, Pearl Pai, Lianhua Chen, Jitka Řehořová, Dita Maixnerová, Roman Šafránek, Ivan Rychlík, M Hrubý, Satu Mäkelä, Kati Vääräniemi, Fernanda Ortiz, É. Alamartine, Maïté Daroux, C. Cartery, François Vrtovsnik, Jean‐Emmanuel Serre, Eleni Stamellou, Volker Vielhauer, Christian Hugo, Klemens Budde, Britta Otte, Martin Nitschke, Evangelia Ntounousi, Ioannis Boletis, Αikaterini Papagianni, Dimitrios Goumenos, Kostas Stylianou, Synodi Zermpala
Management and treatment of glomerular diseases (part 2): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
Brad H. Rovin, Dawn J. Caster, Daniel C. Cattran, Keisha L. Gibson, Jonathan J. Hogan, Marcus J. Moeller, Dario Roccatello, Michael Cheung, David C. Wheeler, Wolfgang C. Winkelmayer, Jürgen Floege, Sharon G. Adler, Charles E. Alpers, Isabelle Ayoub, Arvind Bagga, Sean J. Barbour, Jonathan Barratt, Daniel T.M. Chan, Anthony Chang, Jason Choo, H. Terence Cook, Rosanna Coppo, Fernando C. Fervenza, Agnes B. Fogo, J. G. Fox, Richard J. Glassock, David C.H. Harris, Elisabeth M Hodson, Jonathan J. Hogan, Elion Hoxha, Kunitoshi Iseki, J. Charles Jennette, Vivekanand Jha, David W. Johnson, Shinya Kaname, Ritsuko Katafuchi, A. Richard Kitching, Richard A. Lafayette, Philip Kam‐Tao Li, Adrian Liew, Jicheng Lv, Ana Malvar, Shoichi Maruyama, Juan M. Mejía‐Vilet, Chi Chiu Mok, Patrick H. Nachman, Carla Nester, Eisei Noiri, Michelle M. O’Shaughnessy, Seza Özen, Samir M. Parikh, Hyeong Cheon Park, Chen Au Peh, William F. Pendergraft, Matthew C. Pickering, Évangéline Pillebout, Jai Radhakrishnan, Manish Rathi, Pierre Ronco, William E. Smoyer, Sydney Tang, Vladimı́r Tesař, Joshua M. Thurman, Hernán Trimarchi, Marina Vivarelli, Giles Walters, Angela Yee‐Moon Wang, Scott E. Wenderfer, Jack F.M. Wetzels